Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

References

• Centers for disease control and prevention. HIV/AIDS surveillance report, Atlanta, GA: Centers for Disease Con-trol, February 1993: 1–23.
   Google Scholar
• Hermans P, Lundgren JD, Sommereijns B, et al. Epidemiol-ogy of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS 1996; 10: 911–7.
   PubMed Web of Science ®Google Scholar
• Lundgren JD, Melbye M, Pedersen C, Rosenberg PS, Ger-stoft J. Changing patterns of Kaposi's sarcoma in Danish AIDS patients with complete follow-up. Am J Epidemiol 1995; 141: 652.
   Google Scholar
• Lifson AR, Darrow WW, Hessol NA, et al. Kaposi's sar-coma in a cohort of homosexual and bisexual men. Am J Epidemiol 1990; 131: 221–31.
   PubMed Web of Science ®Google Scholar
• Rutherford GW, Payne SF, Lemp GF. The epidemiology of AIDS-related Kaposi's sarcoma in San Fransisco. J AIDS 1990; 3 (Suppl 1): 4–7.
   Google Scholar
• Schechter MT, Marion SA, Elmslie KD, Ricketts MN, Nault P, Archibald CP. Geographic and birth cohort asso-ciations of Kaposi's sarcoma among homosexual men in Canada. Am J Epidemiol 1991; 134: 485–8.
   PubMed Web of Science ®Google Scholar
• Lundgren JD. Kaposi's sarcoma and its management in AIDS patients-recommendations from a Scandinavian study group. Scand J Infect Dis 1997; 29: 3–12.
   PubMed Web of Science ®Google Scholar
• Brenner AJ, Spencer CM. Liposomal encapsulation: making old and new drugs do new tricks. J Natl Cancer Inst 1989; 81: 13–5.
   PubMedGoogle Scholar
• Coukell AJ, Spencer CM. Polyethylene glycol-liposomal doxorubicin: a review of its pharmacodynamic and pharma-cokinetic properties, and therapeutic efficacy in the manage-ment of AIDS-related Kaposi's sarcoma. Drugs 1997; 53: 520–38.
   PubMed Web of Science ®Google Scholar
• Stewart JSW, Jablonski H, Goebel FD, et al. A randomized comparative trial of liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. Proc Am Soc Clin Oncol 1997; 190A.
   Web of Science ®Google Scholar
• Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sar-coma. J Clin Oncol 1996; 14: 2353–64.
   PubMed Web of Science ®Google Scholar
• Northfelt DW, Dezuble BJ, Thommes JA, et al. Pegylated-liposomal doxorubin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sar-coma: results of a randomized phase III clinical trial. J Clin Oncol 1998; 16: 2445–51.
   PubMed Web of Science ®Google Scholar
• Gill PS, Wernz J, Myers A, et al. Liposomal encapsulated daunorubicin in AIDS-related pulmonary Kaposi's sarcoma. Proc Am Soc Clin Oncol 1997; 16: 55A.
   Web of Science ®Google Scholar
• Krown SE, Metroka C, Wernz J. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uni-form evaluating, response, and staging. J Clin Oncol 1989; 7: 1201–7.
   Google Scholar
• FASS. Farmaceutiska specialiteter i Sverige (Pharmaceutical Specialities in Sweden). Stockholm: Lakemedelsinformation AB, 1998.
   Google Scholar
• Swedish corporation of county councils. Kostnader per inta-gen patient 1993 (Costs per admitted patient 1993). Stock-holm, 1993.
   Google Scholar
• Northfelt DW. AIDS-related Kaposi's sarcoma: still a problem, still an opportunity. J Clin Oncol 1994; 12: 1109–10.
   PubMed Web of Science ®Google Scholar
• Northfelt DW, Dezuble BJ, Thommes JA, et al. Doxoru-bicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol 1997; 15: 653–9.
   PubMed Web of Science ®Google Scholar
• Savage GE, Gable C, Motte K, Dixon C, Becker R. A pharmacokinetic analysis of Kaposi's sarcoma patients based on a clinical trail of ABV versus liposomal daunoru-bicin. Proc XIth Interntl Conf on AIDS, Canada, 1996.
   Google Scholar
• Bennett LC, Golub RM, Stinson TS, et al. A cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 460–5.
   PubMedGoogle Scholar